Results 251 to 260 of about 299,239 (347)

Clinical Characteristics and Prognostic Factors of Severe COVID-19. [PDF]

open access: yesInfect Drug Resist
Yang Y   +5 more
europepmc   +1 more source

PEGylated green halloysite/spinel ferrite nanocomposites for pH sensitive delivery of dexamethasone: A potential pulmonary drug delivery treatment option for COVID-19

open access: green, 2021
B. Rabindran Jermy   +6 more
openalex   +1 more source

AI‐Driven Microphysiological Systems for Advancing Nanoparticle Therapeutics

open access: yesAdvanced Intelligent Systems, EarlyView.
This review outlines recent advances in integrating artificial intelligence with microphysiological systems for nanoparticle evaluation. It highlights data‐driven optimization, image‐based prediction, and AI‐enabled analysis frameworks that advance translational research and support the development of personalized nanomedicine. Nanoparticles (NPs) play
Yedam Lee   +3 more
wiley   +1 more source

Promoting radical healing to facilitate community capacity building among formerly incarcerated Black and Latino men with substance use disorders

open access: yesAmerican Journal of Community Psychology, EarlyView.
Abstract This study reports on a qualitative thematic analysis of secondary data from group session recordings collected as part of the Community Wise Optimization Trial. Community Wise is a multilevel behavioral intervention designed to increase critical consciousness and reduce substance use among formerly incarcerated men living in predominantly ...
Richmond E. Hayes   +4 more
wiley   +1 more source

COVID‐19 pneumonia in kidney transplant recipients: A promising treatment algorithm in the absence of a disease‐specific drug

open access: bronze, 2021
Murat Karataş   +6 more
openalex   +1 more source

Mycosis Fungoides, Sézary Syndrome, and Cutaneous B‐Cell Lymphomas: 2025 Update on Diagnosis, Risk‐Stratification, and Management

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Disease Overview Primary cutaneous lymphomas are a rare and heterogeneous group of extranodal lymphomas that require the integration of clinical and histopathologic data for classification and treatment. Diagnosis Diagnosis and disease classification is based on histopathologic review and immunohistochemical staining of an appropriate skin ...
Alexandra C. Hristov   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy